Investors on the hunt for the next small-cap play may find Bitauto (NYSE:BITA) intriguing. BITA stock has the potential to return massively, but, of course, there is a risk. With a market cap of $699 ... [Read]
The global video game market is expected to surpass $138 billion USD by 2021, thanks to the rise of mobile gaming, as well as innovative technology like cloud gaming and virtual reality. One company that ... [Read]
DVAX stock is taking a major hit this morning as Dynavax (NASDAQ:DVAX) issued a restructuring plan to focus on its vaccine business. When it comes to the world of pharmaceuticals, companies often prefer to focus ... [Read]
HIBB stock jumped more than 15% Friday after Hibbett Sports released its fiscal Q1 report, which surpassed expectations. Here’s what we know. HIBB Stock Up On Q1 Results Hibbett Sports (NASDAQ:HIBB), which operates sporting goods ... [Read]
DOMO stock (NASDAQ:DOMO) is on the radar today. This Utah-based computer software company, Domo Inc, is trading hands for $34.92 USD at present. On a decline of 5% at present, there is potentially a lot ... [Read]
COLUMBUS, May 24, 2019 /CNW/ – Green Growth Brands Inc. (CSE:GGB) (OTC:GGBXF) (“GGB” or “the Company”) is pleased to announce that its board of directors has approved the grant of an aggregate of 595,000 restricted ... [Read]
Leading retail software and technology company VSBLTY Groupe Technologies Corp. (CSE:VSBY) (FRA:5VS) (OTC:VSBGF) revealed some exciting news Thursday that will allow the company to showcase its leading-edge software technology to the growing AI market in Latin America. ... [Read]
AVP stock is one of the biggest gainers in today’s session on the news that Brazil’s Natura Cosmeticos SA agreed to buy rival Avon Products Inc. (NYSE:AVP) in an all-stock deal US cosmetics giant Avon ... [Read]
Penny stocks thrive in a volatile market. And with the US/China trade war intensifying and oil price tensions in the Middle East, there’s real potential in the penny stocks market. That’s because these low-priced shares ... [Read]
AFMD stock is under heavy selling pressure this morning after Affimed NV (NASDAQ:AFMD) announces the termination of Phase 1 clinical program of AFM11, a CD19/CD3-targeting bispecific T cell engager. AFMD stock Tumbles Germany based biopharmaceutical ... [Read]